April 23 (Reuters) - Vitrolife AB VITR.ST :
* MARCH 2020: GOOD GROWTH BUT UNCERTAIN SECOND QUARTER
* Q1 SALES AMOUNTED TO SEK 334 (312) MILLION, CORRESPONDING
TO AN
INCREASE OF 7 PERCENT IN SEK
* Q1 EBITDA SEK 116 MILLION VERSUS SEK 126 MILLION YEAR AGO
* DUE TO GREAT UNCERTAINTY PREVAILING FROM EXTENSIVE SPREAD
OF
COVID-19, VITROLIFE'S BOARD DECIDED TO POSTPONE ANNUAL GENERAL
MEETING TO A LATER DATE
* LARGE REDUCTION IN INFLOW OF ORDERS DUE TO COVID-19 DURING
BEGINNING OF Q2
* SALES DURING FIRST WEEKS OF APRIL AMOUNTED TO
APPROXIMATELY A
THIRD OF THOSE IN CORRESPONDING PERIOD PREVIOUS YEAR
Source text for Eikon: ID:nWkr1pQyK4
Further company coverage: VITR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))